西力生物 | English | 0871-65217109 | | 证券代码:871574
中国天然产物实体库
全部
购物车

Identification of a Novel Small-molecule Agonist for Human G Protein-coupled Receptor 3. J. Pharmacol. Exp. Ther., 2014, 349: 437–443.

来源: J. Pharmacol. Exp. Ther.日期: 2015-02-11

Abstract:

G protein-coupled receptor 3 (GPR3) is an orphan G protein-coupled receptor (GPCR) predominantly expressed in mammalian brain and oocytes. GPR3 plays important roles in these two organs and is known as a G alpha(s)-coupled receptor-activated constitutively in cells. However, the signal transduction pathway and pharmacological function of GPR3 remain unclear because of the lack of a specific ligand. By use of a human embryonic kidney 293 cell line stably expressing FLAG-GPR3-green fluorescent protein, a chemical screening for GPR3 ligands was performed using homogeneous time-resolved fluorescence cAMP assay. Diphenyleneiodonium chloride (DPI) was identified as a novel agonist of GPR3 with weak or no cross-reactivity with other GPCRs. DPI was further characterized to activate several GPR3-mediated signal transduction pathways, including Ca2+ mobilization, cAMP accumulation, membrane recruitment of beta-arrestin2, and receptor desensitization. Parallel studies revealed that the activity of DPI is much more pronounced than sphingosine 1-phosphate, a previously reported GPR3 agonist. Our study identified a novel and specific agonist of GPR3, which provides a useful tool for further study of this orphan GPCR.



联系客服